• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
LIV
Click for more information
0.84% $2.87

Smartshares Healthcare Innovation ETF Units - News & Media

watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No News & Media currently available.

(20min delay)
Last
$2.87 		Change
0.024(0.84%) 		Mkt cap ! n/a
Open High Low Value Volume
$2.83 $2.87 $2.83 $22.73K 7.921K

Buyers (Bids)

No. Vol. Price($)
0 11 $2.80
 

Sellers (Offers)

Price($) Vol. No.
$2.89 661 0
Last trade - 11.25am 10/05/2024 (20 minute delay) ?
LIV (NZSX) Chart

Top Stories

Mantle Minerals to kick off drilling at Mt Berghaus in WA

Mantle Minerals (ASX:MTL) has announced it's kicking off a 122-hole drill run on-site its Mt Berghaus acreage in Western Australia.
Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan Prominence Energy has seen shares rise 33% on news of uranium grading up to 5,269ppm from early sampling work in Kazakhstan.
CBA profits fall 3% in March quarter but funding portfolio is flourishing Commonwealth Bank has reported a 3 percent fall in profits for the March quarter of 2024, compared to the previous quarter.
Raiden opens door to private Mallina in win-win Arrow Gold divestment Raiden Resources has announced its execution of a farm-in deal on-site Raiden's non-core asset, the Arrow gold project.
Recce breathes better on positive lung infection drug pilot test results Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.